Showing results (411-420 of 1,992) with videos related to

Sort By:
Pageof 200
Molecular Biology and Evolution|February 1, 2006
Genetic structure and evolutionary history of a diploid hybrid pine Pinus densata inferred from the nucleotide variation at seven gene lociXiao-Fei Ma, Alfred E Szmidt, Xiao-Ru Wang
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|April 21, 2010
[Clinicopathological characteristics and prognostic significance of young patients with triple-negative breast cancer]Ping Zhang, Bing-he Xu, Fei Ma, et al.
Molecular Brain|December 29, 2012
Orofacial neuropathic pain mouse model induced by Trigeminal Inflammatory Compression (TIC) of the infraorbital nerveFei Ma, Liping Zhang, Danielle Lyons, et al.
Journal of Nanoscience and Nanotechnology|March 14, 2012
Fabrication and characterization of silicon quantum dots in Si-rich silicon carbide filmsGeng-Rong Chang, Fei Ma, Dayan Ma, et al.
Yi Chuan = Hereditas|September 25, 2015
Bioinformatic analysis of cancer-related microRNAs and their target genesXue Zhou, Yi-lan Du, Ping Jin, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 26, 2014
Relationship of serum MMP-7 levels for colorectal cancer: a meta-analysisXiao-Jing Xing, Xiao-Hu Gu, Tian-Fei Ma
Applied Microbiology and Biotechnology|November 4, 2014
Spatially programmed assembling of oxidoreductases with single-stranded DNA for cofactor-required reactionsTianwen David Wang, Fei Ma, Xingyuan Ma, et al.
Accounts of Chemical Research|September 2, 2016
Fluorescent Biosensors Based on Single-Molecule CountingFei Ma, Ying Li, Bo Tang, et al.
Breast Cancer Research and Treatment|December 4, 2010
Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studiesHenri Roché, Pierfranco Conte, Edith A Perez, et al.
Therapeutic Advances in Medical Oncology|September 4, 2024
Dalpiciclib in combination with letrozole/anastrozole or fulvestrant in HR-positive and HER2-negative advanced breast cancer: results from a phase Ib studyQingyuan Zhang, Pin Zhang, Min Yan, et al.
Pageof 200